Blueprint Medicines
BPMC
A$198.67
Share price
0.00%
Change (1 day)
17.78%
Change (1 year)
Categories
Blueprint Medicines (BPMC) - Net assets
Net assets on the balance sheet as of March 2025 : A$0.52 Billion
According to Blueprint Medicines
's latest financial reports the company has A$0.52 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Blueprint Medicines - Net assets on balance sheet (from 2014 to 2025)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $A$0.48 B | 150.47% |
| 2023-12-31 | $A$0.19 B | -74.65% |
| 2022-12-31 | $A$0.75 B | -43.52% |
| 2021-12-31 | $A$1.33 B | -29.96% |
| 2020-12-31 | $A$1.91 B | 188.26% |
| 2019-12-31 | $A$0.66 B | 11.51% |
| 2018-12-31 | $A$0.59 B | -25.58% |
| 2017-12-31 | $A$0.79 B | 170.38% |
| 2016-12-31 | $A$0.29 B | 49.57% |
| 2015-12-31 | $A$0.19 B | 356.54% |
| 2014-12-31 | $A$43.29 M | -2681.18% |
| 2013-12-31 | $-A$1.68 Million |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Isoray
ISR | A$84.41 M | -83.92% | 🇺🇸 USA |
 OPKO Health
OPK | A$2.01 B | 283.38% | 🇺🇸 USA |
 Pacific Biosciences
PACB | A$0.14 B | -73.22% | 🇺🇸 USA |